The leadership team at N1 Life brings a wealth of innovation and perspective to the table. Led by a team with a proven academic reputation, several patented technologies, and demonstrated leadership, we are well-equipped to tackle the challenges of drug discovery and development. Because  since our science is new, we are not constrained by old models. Instead, we mobilize around innovative approaches such as rational design, logical experimentation, and critical thinking to initiate and apply new intelligence to existing disease challenges.

​

At N1 Life, we are agile, creative, and fearless in our pursuit of success. We embrace failure as an opportunity to learn and rapidly take the necessary steps to resolve issues and lead our technology and drug development projects to success. Our fast-paced R&D projects are grounded in science and fueled by our goals. We are confident in the potential of our technology platforms to make a significant impact on the lives of those in need, and we remain steadfast in our commitment to innovation and scientific excellence.

​

N1’s dual-engine (peptide and polymer) powered technology platform is integrated with proprietary, data-driven transporter discovery. Molecular transporters enable drug molecules of different sizes and properties to overcome biological barriers and drug resistance.

​

The company has established its fast-growing and sustainable model that utilizes the platform’s vast and widely applicable potential for both its in-house pipelines and co-development partnerships. N1 Life’s R&D program spans multiple areas, including oncology, dermatology, ophthalmology, neurological diseases, and infectious diseases.